Skip to Main Content

Goodman Lab

Each of us harbors an enormous microbial community.

In the gut, these microbes form a metabolic organ whose genes outnumber those in the human genome by over 100-fold, and whose composition can change overnight. It is becoming increasingly clear that variation in these communities has important consequences for health. The overall goal of the lab is to dissect the mechanisms that commensal gut microbes use to compete, cooperate, and antagonize each other in the gut and to explore how microbiome variation impacts our response to external perturbations, including pathogenic infection and medical drugs.


Microbes metabolising drugs (starts at 0m 45s)

Goodman Lab researchers are investigating whether the gut microbiota can alter the activity of medicinal drugs.

Disentangling host and microbiome contributions to drug metabolism

Video by Maria Zimmermann-Kogadeeva, Michael Zimmermann, and Andrew Goodman


Controlling the activity of microbiome-encoded enzymes

Video by Andrew Goodman, Bentley Lim